MX376782B - Métodos de administración de composiciones de amantadina. - Google Patents

Métodos de administración de composiciones de amantadina.

Info

Publication number
MX376782B
MX376782B MX2017005578A MX2017005578A MX376782B MX 376782 B MX376782 B MX 376782B MX 2017005578 A MX2017005578 A MX 2017005578A MX 2017005578 A MX2017005578 A MX 2017005578A MX 376782 B MX376782 B MX 376782B
Authority
MX
Mexico
Prior art keywords
methods
administering amantadine
compositions
amantadine compositions
administering
Prior art date
Application number
MX2017005578A
Other languages
English (en)
Other versions
MX2017005578A (es
Inventor
David Chernoff
Gregory T Went
Jack Nguyen
Timothy J Fultz
Original Assignee
Adamas Pharma Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adamas Pharma Llc filed Critical Adamas Pharma Llc
Publication of MX2017005578A publication Critical patent/MX2017005578A/es
Publication of MX376782B publication Critical patent/MX376782B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describen los métodos de administración de amantadina para mejorar los trastornos de movimiento, así como las composiciones adecuadas para ello.
MX2017005578A 2014-11-04 2015-11-03 Métodos de administración de composiciones de amantadina. MX376782B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462075137P 2014-11-04 2014-11-04
PCT/US2015/058872 WO2016073510A1 (en) 2014-11-04 2015-11-03 Methods of administering amantadine compositions

Publications (2)

Publication Number Publication Date
MX2017005578A MX2017005578A (es) 2018-01-11
MX376782B true MX376782B (es) 2025-03-07

Family

ID=55909712

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017005578A MX376782B (es) 2014-11-04 2015-11-03 Métodos de administración de composiciones de amantadina.

Country Status (14)

Country Link
US (1) US20160228388A1 (es)
EP (2) EP3215132B1 (es)
JP (1) JP6735020B2 (es)
CN (1) CN107205950B (es)
AU (1) AU2015343199B2 (es)
BR (1) BR112017009289A2 (es)
CA (1) CA2966195C (es)
ES (1) ES2865278T3 (es)
HU (1) HUE055779T2 (es)
MX (1) MX376782B (es)
PL (1) PL3215132T3 (es)
PT (1) PT3215132T (es)
SI (1) SI3215132T1 (es)
WO (1) WO2016073510A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10154971B2 (en) 2013-06-17 2018-12-18 Adamas Pharma, Llc Methods of administering amantadine
MX2020002078A (es) * 2017-08-24 2020-09-21 Adamas Pharma Llc Composiciones de amantadina, preparaciones de estas y métodos de uso.
TR201720406A2 (tr) 2017-12-14 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Bi̇r i̇skelet kasi gevşeti̇ci̇si̇ ve bi̇r multi̇pl skleroz tedavi̇ edi̇ci̇ ajan i̇çeren kombi̇nasyonlar
EP3810110A4 (en) 2018-06-21 2022-03-16 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi COMBINATION OF FINGOLIMOD AND AMANTADINE
TR201818307A2 (tr) * 2018-11-30 2020-06-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Di̇meti̇l fumarat i̇çeren bi̇r kompozi̇syon
TR201818859A2 (tr) 2018-12-07 2020-06-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Di̇meti̇l fumarat ve en az bi̇r kas gevşeti̇ci̇ ajan i̇çeren bi̇r kombi̇nasyon
TR201819202A2 (tr) 2018-12-12 2020-06-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Bi̇r multi̇pl skleroz ajani ve en az bi̇r kas relaksan ajan i̇çeren bi̇r kombi̇nasyon
TR201820976A2 (tr) * 2018-12-28 2020-07-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Fi̇ngoli̇mod ve bi̇r spazmoli̇ti̇k i̇çeren farmasöti̇k kombi̇nasyonlar

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5221536A (en) 1990-05-07 1993-06-22 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5358721A (en) 1992-12-04 1994-10-25 Alza Corporation Antiviral therapy
AUPN605795A0 (en) 1995-10-19 1995-11-09 F.H. Faulding & Co. Limited Analgesic pharmaceutical composition
WO2006053067A2 (en) * 2004-11-09 2006-05-18 Prestwick Pharmaceuticals, Inc. Combination of amantadine and a tetrabenazine compound for treating hyperkinetic disorders
US8058291B2 (en) 2005-04-06 2011-11-15 Adamas Pharmaceuticals, Inc. Methods and compositions for the treatment of CNS-related conditions
US7619007B2 (en) * 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
WO2006058236A2 (en) 2004-11-24 2006-06-01 Neuromolecular Pharmaceuticals, Inc. Composition comprising an nmda receptor antagonist and levodopa and use thereof for treating neurological disease
US8574626B2 (en) 2004-12-03 2013-11-05 Osmotica Kereskedelmi és Szolgáltató KFT Osmotic device containing amantadine and an osmotic salt
WO2006089066A1 (en) * 2005-02-15 2006-08-24 Neuromolecular Pharmaceuticals, Inc. Combinations therapy for treatment of demyelinating conditions
US7981930B2 (en) 2007-03-13 2011-07-19 Adamas Pharmaceuticals, Inc. Compositions and kits for treating influenza
US8741343B2 (en) * 2009-12-02 2014-06-03 Adamas Pharmaceuticals, Inc. Method of administering amantadine prior to a sleep period
WO2014093475A1 (en) * 2012-12-11 2014-06-19 Acorda Therapeutics, Inc. Methods for treating parkinson's disease using aminopyridines
US10154971B2 (en) * 2013-06-17 2018-12-18 Adamas Pharma, Llc Methods of administering amantadine

Also Published As

Publication number Publication date
WO2016073510A1 (en) 2016-05-12
US20160228388A1 (en) 2016-08-11
CN107205950B (zh) 2021-06-04
EP3215132A4 (en) 2018-07-11
BR112017009289A2 (pt) 2017-12-19
EP3909569A1 (en) 2021-11-17
PT3215132T (pt) 2021-05-07
HUE055779T2 (hu) 2021-12-28
ES2865278T3 (es) 2021-10-15
SI3215132T1 (sl) 2021-11-30
JP2017533211A (ja) 2017-11-09
MX2017005578A (es) 2018-01-11
AU2015343199B2 (en) 2021-04-08
EP3215132A1 (en) 2017-09-13
CA2966195C (en) 2024-04-30
AU2015343199A1 (en) 2017-05-18
CN107205950A (zh) 2017-09-26
EP3215132B1 (en) 2021-01-27
JP6735020B2 (ja) 2020-08-05
CA2966195A1 (en) 2016-05-12
PL3215132T3 (pl) 2021-10-11

Similar Documents

Publication Publication Date Title
ZA202004557B (en) Modulatory polynucleotides
PH12016501966A1 (en) Compounds and compositions as toll-like receptor 7 agonists
MX376782B (es) Métodos de administración de composiciones de amantadina.
PH12016501151A1 (en) Nrf2 regulators
MX2021014128A (es) Polimorfos de selinexor.
MD20150091A2 (ro) Compuşi antivirali
MX2017008442A (es) Uso de picolinamidas como fungicidas.
TW201613853A (en) Synthesis of polycyclic-carbamoylpyridone compounds
MY177031A (en) Tetrahydropyridopyrazines modulators of gpr6
AU2015287674B2 (en) Topical antiviral compositions and methods of using the same
EP3102554A4 (en) Conversion of 2,3-butanediol to butadiene
AU2018253594A1 (en) Dihydroxyphenyl neurotransmitter compounds, compositions and methods
MX345926B (es) Nuevas composiciones, producción de las mismas y uso de las mismas para la producción de poliamidas coladas.
PH12017500459A1 (en) Azetidinyloxyphenylpyrrolidine compounds
MY180844A (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
AU2018253600A1 (en) Dosage forms and therapeutic uses of l-4-chlorokynurenine
IN2014CH00840A (es)
IN2014CH00151A (es)
MX2015016603A (es) Composiciones de corticosteroides.
IN2013MU01113A (es)
IN2014CH00304A (es)
EA201691465A1 (ru) Средство для лечения сердечно-сосудистых заболеваний
IN2013CH04314A (es)
IN2013MU03768A (es)
PH12017501147A1 (en) Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs

Legal Events

Date Code Title Description
FG Grant or registration
PD Change of proprietorship

Owner name: ADAMAS PHARMA, LLC